Merck KGaA’s oral TLR7/8 inhibitor enpatoran has failed to meet the primary endpoint in a subgroup of patients, but ...

While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.

Q4 2024 Results Conference Call March 6, 2025 8:00 AM ETCompany ParticipantsFlorian Schraeder - Head of Investor ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Dassault Aviation could cut its aircraft manufacturing workload at its Little Rock facility, located in the U.S. state of Arkansas, if President Trump goes ahead with his threat to impose a 25% tariff ...

Preparations for submission of a Biologics License Application (BLA) for Cylembio® (imsapepimut and etimupepimut, adjuvanted) to FDA by year end ...